Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $159.3900 (-0.25%) ($158.8200 - $160.9400) on Wed. Nov. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 88 | Latest Price | $159.3900(-0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XBI(13%) XLV(13%) DIA(11%) SPLV(11%) XLP(10%) | Factors Impacting ABBV price | ABBV will decline at least -0.815% in a week (0% probabilities). VIXM(-11%) UUP(-6%) JETS(-5%) IWN(-5%) XHB(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0.7 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $156.69(1.72%) | 10 Day Moving Average | $154.2(3.37%) | 20 Day Moving Average | $150.87(5.65%) | To recent high | -0.3% | To recent low | 18.8% | Market Cap | $281.209b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |